NCT04983342 is a NA clinical trial of Apollo Armband in Fatigue, sponsored by Margaret Quinn Rosenzweig.

Who is sponsoring NCT04983342?

NCT04983342 is sponsored by Margaret Quinn Rosenzweig.

What drugs are being tested in NCT04983342?

Interventions in NCT04983342: Apollo Armband.

What condition does NCT04983342 study?

NCT04983342 studies Fatigue, Metastatic Breast Carcinoma.

Is NCT04983342 still recruiting?

NCT04983342 is currently completed. Last updated 21 June 2024.

Last reviewed 2024-06-21 · How we verify

NCT04983342

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Apollo Device for Metastatic Breast Cancer (MBC)

Completed NA Last updated 21 June 2024

What this trial tests

NA trial testing Apollo Armband in Fatigue in 27 participants. Completed in 9 August 2022.

Timeline

1 February 2021

Primary endpoint
9 August 2022

9 August 2022

Quick facts

Lead sponsor	Margaret Quinn Rosenzweig
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	27
Start date	1 February 2021
Primary completion	9 August 2022
Estimated completion	9 August 2022
Sites	1 location across United States

Drugs / interventions tested

Apollo Armband

Conditions studied

Fatigue — all drugs for Fatigue →
Metastatic Breast Carcinoma — all drugs for Metastatic Breast Carcinoma →

Sponsor

Margaret Quinn Rosenzweig

Who can join

Adults 18 to 100, female only, with Fatigue or Metastatic Breast Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-arm, open label pilot intervention study with outcomes measured by electronic survey and chart review evaluating a wearable device called Apollo, which is similar to a FitBit but emits vibrations. Our primary objective is to assess whether or not Apollo can help with symptoms of fatigue and pain in patients with Metastatic Breast Cancer (MBC).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fatigue

Currently open trials in the same condition.

NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07386691 — Comparing Effect of Intradialytic Aerobic Exercise Versus Incentive Spirometer on Fatigue and Sleep Quality Among Hemodi · NA · active not recruiting
NCT06819254 — Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04983342 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Margaret Quinn Rosenzweig
Last refreshed: 21 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04983342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing